Cargando…
Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results
Research and development (R&D) costs factor into considerations of the tradeoffs between prices, intellectual property protection, and incentivizing innovation, all of which can have implications for policy development. Yet, there is little consensus on the actual cost of R&D for new drugs....
Autores principales: | Rennane, Stephanie, Baker, Lawrence, Mulcahy, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855407/ https://www.ncbi.nlm.nih.gov/pubmed/35170336 http://dx.doi.org/10.1177/00469580211059731 |
Ejemplares similares
-
EHealth Investment Appraisal in Africa: A Scoping
Review
por: Broomhead, Sean C., et al.
Publicado: (2021) -
Implementation Outcomes and Indicators as a New Challenge in Health
Services Research: A Systematic Scoping Review
por: Willmeroth, Tabea, et al.
Publicado: (2019) -
Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China
por: Mingge, Xia, et al.
Publicado: (2023) -
Increasing Health Insurance Enrollment in Low- and Middle-Income
Countries: What Works, What Does Not, and Research Gaps: A Scoping
Review
por: James, Nigel, et al.
Publicado: (2022) -
Drug-Resistant Tuberculosis Stigma Among HealthCare Workers Toward the Development of a Stigma-Reduction Strategy: A Scoping Review
por: Liboon Aranas, Lolita, et al.
Publicado: (2023)